Research Article

Effects of Liraglutide on Left Ventricular Function: A Meta-Analysis of Randomized, Placebo-Controlled Trials

Table 1

Characteristics of included studies.

StudyYearLG/CGSample size, nAge, yMales, n (%)Hypertension, n (%)Diabetes, n (%)Smokers, n (%)Follow-up

Kumarathurai et al. [18]2021LG3063.1 ± 6.624 (80)23 (77)30 (100)14 (36)12 weeks
CG30

Paiman et al. [19]2020LG2255 ± 118 (36)NR22 (100)8 (36)26 weeks
CG2555 ± 911 (44)25 (100)5 (20)

Wagner et al. [20]2019LG1253.2 ± 9.74 (33)7 (58)12 (100)2 (17)6 months
CG1252.6 ± 13.85 (42)8 (67)12 (100)3 (25)

Bizino et al. [21]2019LG2360 ± 614 (61)NR23 (100)13 (56)26 weeks
CG2659 ± 715 (58)26 (100)18 (69)

Jorgensen et al. [22]2017LG1657 ± 10NRNR16 (100)NR16 weeks
CG1616 (100)

Zhang et al. [23]2017LG2659.1 ± 11.820 (77)17 (65)5 (19)15 (58)1 week
CG2658.7 ± 11.419 (73)16 (62)7 (27)17 (65)

Jorsal et al. [24]2017LG12265 ± 9.2109 (89)NR39 (32)25 (21)24 weeks
CG11965 ± 10.7106 (89)35 (29)23 (19)

Chen et al. [25]2016LG4558.0 ± 11.734 (76)27 (60)9 (20)25 (56)3 months
CG4559.0 ± 12.132 (71)29 (64)13 (28)27 (60)

Kumarathurai et al. [26]2016LG3061.8 ± 7.631 (79)29 (74)30 (100)14 (36)12 weeks
CG30

Chen et al. [27]2016LG3957.1 ± 13.027 (69)18 (46)5 (13)13 (33)3 months
CG3858.7 ± 12.726 (68)19 (48)7 (18)14 (37)

LG: liraglutide group; CG: control group; NR: not reported.